Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance
Asparaginase (ASNase) is a widely applied chemotherapeutic drug that is used to treat Acute Lymphoblastic Leukemia (ALL); however, immune responses and silent inactivation of the drug often limit its bioavailability. Many strategies have been proposed to overcome these drawbacks, including the devel...
Guardado en:
Autores principales: | Francisca Villanueva-Flores, Andrés Zárate-Romero, Alfredo G. Torres, Alejandro Huerta-Saquero |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea8024f47a864400801b0a6f7d3cc928 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study
por: Dong Won Baek, et al.
Publicado: (2021) -
Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia
por: Zohreh Mousavi, et al.
Publicado: (2021) -
Genetic Variation in <i>ABCC4</i> and <i>CFTR</i> and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic Leukemia
por: Thies Bartram, et al.
Publicado: (2021) -
Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity
por: Esteban Cruz, et al.
Publicado: (2021) -
Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy
por: Seung Rim Hwang, et al.
Publicado: (2021)